Stephens Consulting, LLC Edgewise Therapeutics, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 30 shares of EWTX stock, worth $444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$444% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$223 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$132 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$97 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$91.2 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$89.2 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $936M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...